Literature DB >> 26132228

Predictors of Health Care Use of Women with Breast Cancer: A Systematic Review.

Deborah N N Lo-Fo-Wong1, Kate Sitnikova1, Mirjam A G Sprangers1, Hanneke C J M de Haes1.   

Abstract

The aim of this study was to identify predictors of health care use among women with breast cancer by conducting a systematic review. Potentially relevant studies were identified by searching the PubMed, EMBASE, PsycINFO, CINAHL, and Cochrane Library databases. Also, backward and forward citation searches were performed. Studies were selected if they addressed associations between (a) sociodemographic, enabling (e.g., income), clinical and health related, or psychosocial predictors, and (b) medical, psychosocial, or paramedical health care use of adult women with breast cancer. The health care types of interest were hospital utilization and provider visits. An evaluation of aggregated findings was performed to determine consistency of findings between studies. Sixteen studies were included in the review. Higher age, a more advanced cancer stage, more comorbid disorders, having a mastectomy, a lymph node dissection, and breast reconstruction were consistently associated with higher hospital utilization. None of the patient characteristics were consistently associated with medical, psychosocial, or paramedical health care use-but psychosocial or paramedical associations were also less examined. In conclusion, sociodemographic, medical, and treatment-related factors were consistently associated with (higher) health care use of breast cancer patients. Practitioners may use this information to anticipate future use of subgroups of patients. Results may also be used in the development of interventions that target relevant predictors, to reduce patients' health care use and accompanying health care costs. Furthermore, more research is needed to identify predictors of psychosocial and paramedical health care use.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  breast cancer; health care use; systematic review

Mesh:

Year:  2015        PMID: 26132228     DOI: 10.1111/tbj.12447

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  10 in total

1.  Direct Medical Costs, Productivity Loss Costs and Out-Of-Pocket Expenditures in Women with Breast Cancer in Latin America and the Caribbean: A Systematic Review.

Authors:  Alfredo Palacios; Carlos Rojas-Roque; Lucas González; Ariel Bardach; Agustín Ciapponi; Claudia Peckaitis; Andres Pichon-Riviere; Federico Augustovski
Journal:  Pharmacoeconomics       Date:  2021-03-30       Impact factor: 4.981

2.  Alterations in expression levels of genes in p53-related pathways determined using RNA-Seq analysis in patients with breast cancer following CIK therapy.

Authors:  Zuowei Hu; Xiaoye Zhang; Hang Yang; Shuanglai Qin; Yaqi Liu; Wei Xiong; Bing Yuan; Liping Li; Weiqi Yao; Dongcheng Wu
Journal:  Oncol Lett       Date:  2017-10-18       Impact factor: 2.967

3.  MicroRNA-210 interacts with FBXO31 to regulate cancer proliferation cell cycle and migration in human breast cancer.

Authors:  Dayue Liu; Haoming Xia; Fang Wang; Cui Chen; Jianting Long
Journal:  Onco Targets Ther       Date:  2016-08-23       Impact factor: 4.147

4.  Global treatment costs of breast cancer by stage: A systematic review.

Authors:  Li Sun; Rosa Legood; Isabel Dos-Santos-Silva; Shivani Mathur Gaiha; Zia Sadique
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

5.  Social factors influencing utilization of home care in community-dwelling older adults: a scoping review.

Authors:  Jasmine C Mah; Susan J Stevens; Janice M Keefe; Kenneth Rockwood; Melissa K Andrew
Journal:  BMC Geriatr       Date:  2021-02-27       Impact factor: 3.921

6.  The P.I.N.K. Study Approach for Supporting Personalized Risk Assessment and Early Diagnosis of Breast Cancer.

Authors:  Michela Franchini; Stefania Pieroni; Edgardo Montrucchio; Jacopo Nori Cucchiari; Cosimo Di Maggio; Enrico Cassano; Brunella Di Nubila; Gian Marco Giuseppetti; Alberto Nicolucci; Gianfranco Scaperrotta; Paolo Belli; Sonia Santicchia; Sabrina Molinaro
Journal:  Int J Environ Res Public Health       Date:  2021-03-02       Impact factor: 3.390

7.  Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer.

Authors:  Rashmi Verma; Ruth E Foster; Kieran Horgan; Katherine Mounsey; Helen Nixon; Natuley Smalle; Thomas A Hughes; Clive R D Carter
Journal:  Breast Cancer Res       Date:  2016-01-26       Impact factor: 6.466

8.  p53 inhibits the expression of p125 and the methylation of POLD1 gene promoter by downregulating the Sp1-induced DNMT1 activities in breast cancer.

Authors:  Liang Zhang; Weiping Yang; Xiao Zhu; Changyuan Wei
Journal:  Onco Targets Ther       Date:  2016-03-10       Impact factor: 4.147

9.  Risk factors of unmet needs among women with breast cancer in the post-treatment phase.

Authors:  Deborah N N Lo-Fo-Wong; Hanneke C J M de Haes; Neil K Aaronson; Doris L van Abbema; Mathilda D den Boer; Marjan van Hezewijk; Marcelle Immink; Ad A Kaptein; Marian B E Menke-Pluijmers; Anna K L Reyners; Nicola S Russell; Manon Schriek; Sieta Sijtsema; Geertjan van Tienhoven; Mathilde G E Verdam; Mirjam A G Sprangers
Journal:  Psychooncology       Date:  2019-12-16       Impact factor: 3.894

10.  Unmet Health Needs of Roma Women in the Two Biggest Roma Communities in the Republic of Srpska, Bosnia and Herzegovina.

Authors:  Stela Stojisavljevic; Milkica Grabez; Kristefer Stojanovski
Journal:  Front Public Health       Date:  2020-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.